Navigation Links
The Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis
Date:6/11/2013

DUBLIN, June 11, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/hrlbkd/top_five_global) has announced the addition of the "Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The fragmented market has observed some changes in the competitive landscape during the last five years. The top players are expanding their footprints in the emerging markets of China, India, Brazil, Latin America, and Eastern Europe. They are strengthening their technological and R&D structure by targeted merger and acquisition activities to help develop and market innovative drugs.

This report briefly discusses the subject companies, their geographic footprints, financial metrics, market performance, marketing and corporate strategies, and provides SWOT analysis of each. The report indicates that increased regulation of the pharmaceutical industry is expected to increase the industry's cost structure and reduce revenue as getting drugs to market becomes a longer and more expensive process. Regulatory approval for the introduction of biogenerics/biosimilars, generic versions of biologic drugs, increases the threat of uncertainty to the pharmaceutical market.

This report projects the major drivers of the industry. Growth in sectors such as health awareness among populations, R&D expenditures, sales of prescribed medicine and demand for generic medicines are expect to continue to provide huge demand for medicines. Various governments' increased spending in infectious and chronic degenerative diseases as well as anti-diabetes and cardiovascular drugs has driven the growth in sales of the pharmaceutical industry.

The report gives an overview of the top five global pharmaceutical companies:

- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Sanofi-Aventis


For more information visit http://www.researchandmarkets.com/research/hrlbkd/top_five_global

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vocera Chief Medical Officer Bridget Duffy Keynotes at Top Global Health Conferences
2. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
3. Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
4. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
5. BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
6. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
7. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
8. Global In Vitro Diagnostics Markets Outpace Pharma Industry Growth, finds Frost & Sullivan
9. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
10. In Vitro Diagnostics - A Global Market Overview
11. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):